Studies on the chemotherapy of human opisthorchiasis: III. Minimum effective dose of praziquantel
A clinical trial of praziquantel was carried out in patients with opisthorchiasis using low dosages with 30 and 60 days follow-up. In group III, 30 patients treated with praziquantel 25 mg per kg body weight bid, for one day yielded a cure rate of 88%. In group IV, 12 patients received 25 mg per kg...
Saved in:
Main Authors: | D. Bunnag, T. Harinasuta |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/30202 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Studies on the chemotherapy of human opisthorchiasis: Effective dose of praziquantel in heavy infection
by: S. Pungpak, et al.
Published: (2018) -
Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel
by: D. Bunnag, et al.
Published: (2018) -
Clinical and laboratory evaluation of praziquantel in opisthorchiasis
by: S. Pungpak, et al.
Published: (2018) -
Pharmacokinetics of praziquantel in patients with opisthorchiasis
by: K. Na Bangchang, et al.
Published: (2018) -
Studies on the chemotherapy of human opisthorchiasis: II. Clinical trial of niclofolan
by: D. Bunnag, et al.
Published: (2018)